165 related articles for article (PubMed ID: 29999199)
1. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
[TBL] [Abstract][Full Text] [Related]
2. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
[TBL] [Abstract][Full Text] [Related]
5. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Bozovic I; Kacar A; Cobeljic M; Dejanovic I; Stevic Z; Basta I
J Peripher Nerv Syst; 2019 Jun; 24(2):180-186. PubMed ID: 30973184
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry.
Mork H; Motte J; Fisse AL; Grüter T; Brünger J; Stoykova Z; Bulut Y; Athanasopoulos D; Sturm D; Tegenthoff M; Gold R; Enax-Krumova E; Pitarokoili K
Eur J Neurol; 2022 Jul; 29(7):2109-2120. PubMed ID: 35357725
[TBL] [Abstract][Full Text] [Related]
8. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
[TBL] [Abstract][Full Text] [Related]
9. Employment status of patients with Charcot-Marie-Tooth type 1A.
Bjelica B; Brankovic M; Bozovic I; Palibrk A; Kacar A; Rakocevic-Stojanovic V
Acta Neurol Belg; 2022 Jun; 122(3):641-646. PubMed ID: 33491123
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
[TBL] [Abstract][Full Text] [Related]
11. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
[TBL] [Abstract][Full Text] [Related]
13. Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Merkies IS; Kieseier BC
Eur Neurol; 2016; 75(3-4):199-206. PubMed ID: 27077919
[TBL] [Abstract][Full Text] [Related]
14. Fatigue in chronic inflammatory demyelinating polyneuropathy.
Gable KL; Attarian H; Allen JA
Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648
[TBL] [Abstract][Full Text] [Related]
15. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
[TBL] [Abstract][Full Text] [Related]
16. Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Peric S; Basta I; Rakocevic-Stojanovic V; Lavrnic D; Stevic Z; Radovanovic S
J Clin Neurosci; 2020 Oct; 80():6-10. PubMed ID: 33099368
[TBL] [Abstract][Full Text] [Related]
17. Impact of environmental factors and physical activity on disability and quality of life in CIDP.
Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Beghi E; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Schenone A; Liberatore G; Peci E; Spina E; Tronci S; Cotti Piccinelli S; Toscano A; Gentile L; Piccolo L; Leonardi L; Mataluni G; Ruiz M; Sabatelli M; Santoro L; Nobile-Orazio E;
J Neurol; 2020 Sep; 267(9):2683-2691. PubMed ID: 32430573
[TBL] [Abstract][Full Text] [Related]
18. Postural tremor and chronic inflammatory demyelinating polyneuropathy.
Cao Y; Menon P; Ching-Fen Chang F; Mahant N; Geevasinga N; Fung VS; Vucic S
Muscle Nerve; 2017 Mar; 55(3):338-343. PubMed ID: 27421831
[TBL] [Abstract][Full Text] [Related]
19. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Tackenberg B; Haas J; Kieseier BC
BMC Neurol; 2023 May; 23(1):207. PubMed ID: 37237267
[TBL] [Abstract][Full Text] [Related]
20. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
